Evidence map›Paper›PMID 28691708›Full record

ArticleNature communications2017

An exported protein-interacting complex involved in the trafficking of virulence determinants in Plasmodium-infected erythrocytes.

Steven Batinovic, Emma McHugh, Scott A Chisholm, Kathryn Matthews, Boiyin Liu, Laure Dumont, Sarah C Charnaud, Molly Parkyn Schneider, Paul R Gilson, Tania F de Koning-Ward and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MAHRP2 is required for tether formation and cytoadherence inFrontiers in cellular and infection microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. International journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Frontiers in molecular biosciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Steven BatinovicDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0001-8950-793X
Emma McHughDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Scott A ChisholmSchool of Medicine, Deakin University, Waurn Ponds, Victoria 3220, Australia.
Kathryn MatthewsSchool of Medicine, Deakin University, Waurn Ponds, Victoria 3220, Australia.
Boiyin LiuDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Laure DumontDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Sarah C CharnaudMacfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria 3004, Australia.
Molly Parkyn SchneiderDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Paul R GilsonMacfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria 3004, Australia.
Tania F de Koning-WardSchool of Medicine, Deakin University, Waurn Ponds, Victoria 3220, Australia.
Matthew W A DixonDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Leann TilleyDepartment of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
The University of Melbourne · AUDeakin University · AUBurnet Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The malaria parasite, Plasmodium falciparum, displays the P. falciparum erythrocyte membrane protein 1 (PfEMP1) on the surface of infected red blood cells (RBCs). We here examine the physical organization of PfEMP1 trafficking intermediates in infected RBCs and determine interacting partners using an epitope-tagged minimal construct (PfEMP1B). We show that parasitophorous vacuole (PV)-located PfEMP1B interacts with components of the PTEX (Plasmodium Translocon of EXported proteins) as well as a novel protein complex, EPIC (Exported Protein-Interacting Complex). Within the RBC cytoplasm PfEMP1B interacts with components of the Maurer's clefts and the RBC chaperonin complex. We define the EPIC interactome and, using an inducible knockdown approach, show that depletion of one of its components, the parasitophorous vacuolar protein-1 (PV1), results in altered knob morphology, reduced cell rigidity and decreased binding to CD36. Accordingly, we show that deletion of the Plasmodium berghei homologue of PV1 is associated with attenuation of parasite virulence in vivo.

Indexed as

Host-Pathogen InteractionsAnimalsCarrier ProteinsCell AdhesionFemaleGene Knockdown TechniquesMembrane ProteinsMice, Inbred C57BLPlasmodium bergheiPlasmodium falciparumProtein TransportProtozoan ProteinsCarrier Proteinserythrocyte membrane protein 1, Plasmodium falciparumMembrane ProteinsPfsbp1 protein, Plasmodium falciparumProtozoan ProteinsREX1 protein, Plasmodium falciparum

Identifiers

PMID28691708
PMCPMC5508133
OpenAlexW2726949767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.